Events

Starting with an overview of beyond rule of five (bRo5) drugs and the key challenges behind these drugs, in this webinar, experts will discuss how intracellular concentrations of drugs is influenced by drug-transporting proteins and metabolizing enzymes and how they are involved in delivering effective drug as well as determining toxicity and drug interactions. The […]

Medical device companies endeavour to connect their innovative products, to enable collaboration with patients. While they understand the importance of data to enhance personalized remote patient monitoring and ensure the continuum of care they can’t afford investing in complex and timely projects and implementation. In this webinar you will learn: How to successfully develop and […]

Medicon Valley Alliance have the pleasure to invite you to the 11th meeting within the Medtech Network. The meeting will be hosted by MVA member company Key2Compliance and will focus on Clinical trials in Medtech.  We are looking forward to host a physical event in Copenhagen with insightful presentations followed by networking. The medical device […]

Opportunities in finance, investments and precision medicine Welcome to the 10th edition of our international partnering event The Future of Swedish & Danish Life Science. This years themes are: Reflections on the past decade, and looking to the future Investments and finance Precision medicine Date: 2nd September 2021 Venue: Medicon Village, Lund, Sweden The event […]

Welcome to the 9th edition of New updates in Drug Formulation & Bioavailability. This event is a platform based on the concept of synergies between “science” and “business”. Meet R&D people, the pharma industry, increase your awareness and gain more knowledge about this exciting topic. The presented content and topics will focus on advancements in […]

Drug development in oncology is undergoing several changes brought about by precision medicine, which makes it appealing to move efficacy assessment to earlier-phase trials and questions the need for randomized trials. Indeed, some remarkably efficacious drugs have even been approved based on uncontrolled phase I or II trials. With very few exceptions, we challenge the […]

Medicon Valley Alliance together with member company Ascelia Pharma have the pleasure to invite you to the 11th meeting of the Medicon Valley Alliance Oncology Network on the 24th of August, 2021. Rare disease affects a small number of patients; the European Medicines Agency defines rare disease where the prevalence of the disease is less […]

Join us for the live streaming from the presentation of the new analysis Life Science Across the Øresund The new analysis Life science across the Øresund will be presented during live streaming on 22nd of June 2021. The analysis will show the comprehensive collaboration across Øresund with regards to commuting, workforce, investments, businesses and research. […]

Introducing the new single-use separator, Alfa Laval CultureOne™ From greater flexibility to shorten the time to market, to increased assurance of patient safety, several factors have driven the growing transition to single-use processing in the biopharma industry. More manufacturers are seeking solutions that enable smaller batches and predictable, scalable production. Of course, this requires compact […]

Implementing and Validating Meso Scale Discovery – ECL Detection for Clinical Trials When implementing biomarker strategies for clinical trials, it is not only important to choose the right analysis platform but also have the assays validated and performed to meet regulatory submission requirements. Unilabs Serving Pharma group, in collaboration with Meso-Scale Discovery (MSD) will present […]

A well-functioning research infrastructure is a key fundamental to support science and to accelerate innovation within academia and industry. Researchers and individual companies requires access to complex technologies and often lack some of the expertise required in-house to address all aspects of complex research questions. Many national, regional and private initiatives have invested in significant […]

Discovering and characterizing novel drug candidates for preclinical development depends on innovative and reliable science. Charles River’s unique combination of integrated, multidisciplinary drug discovery expertise and unparalleled scope of capabilities in targets, platforms, and therapeutic areas allow us to deliver depth and breadth in science with data and insight you can trust to progress your […]

The success of several drugs in amorphous systems in the commercial market confirm that amorphous drug delivery system is one the efficient ways of enhancing solubility and optimizing bioavailability of poorly soluble drugs. Spray drying and hot melt extrusion are the two technologies most widely used for the preparation of amorphous solid dispersion. In addition, […]

Keep up with transparency trends and leverage disclosure data for patient engagement and recruitment While the complexity and costs of clinical trial transparency regulations continue to increase, there are growing opportunities to leverage investments in disclosure compliance. Understanding the requirements and trends helps identify opportunities to reuse the disclosure data beyond submissions to regulatory authorities […]

The 7 most important things to update in your technical documentation and your QMS, and how they interact Do you want to understand which parts of the MDR that you as medical device manufacturer must have in place on May 26th and what you need to adjust in your technical documentation, when CE-marking a device […]

Join the Greater Copenhagen Microbiome Summit for the latest scientific trends and insights within the microbiome field from companies like BioGaia, Chr. Hansen, Ferring and Novozymes as well as academic experts. The Greater Copenhagen Microbiome Summit offers a digital venue for bringing together microbiome scientists and companies to define the state of microbiome research and […]

Save the dates With so much changing quickly, we have also evaluated the situation regarding the upcoming Nordic Life Science Days and Nordic Life Science Investment Day, currently scheduled in Malmö for 19-21 April 2021. The health and safety of our attendees, exhibitors, sponsors, speakers, and partners are our top priority. And with so many […]

Members of Medicon Valley Alliance are invited to attend the Ordinary General Meeting 2021 Date: Monday April 12th, 2021 Time: 17.00-18.00 Venue: TBD Documents for the Ordinary General Meeting: Convening notice for the Ordinary General Meeting 2021 Medicon Valley Alliance Annual Report 2020 Power of Attorney – Ordinary General Meeting 2021 Bylaws Registration Please register […]

The webinar offers current insights to securing ovarian female function. MVA is partner in the ReproUnion project, where the regional universities, hospitals and industry are working together to solve five major global reproductive challenges, which are of great individual and social concern. Organizers: ReproUnion’s Challenge 3 group Participation: It is free to attend and the […]

Medicon Valley Alliance is hosting a digital meeting focusing on identifying and attracting funding for companies in the early stages of development. Attracting funds for early stage lifescience companies is challenging, however necessary, to ensure further development and growth. Funding can come from many different sources; public soft money, business angels, specialized VCs and through […]

Delivering patient centric care through digital transformation in Medtech Medicon Valley Alliance Medtech Network is hosting a digital network meeting on the theme of digital transformation in the Medtech industry with focus on patient centric care by highlighting some recent developments within the field in the Öresund region. Medicon Valley feature world class healthcare and […]

Biopharmaceutical products in development continue to increase in complexity, which effects how companies choose to express proteins and eventually, manufacture at clinical and commercial scale. In this webinar, co-organized by Medicon Valley Alliance and Catalent, experts from Catalent Biologics and Sartorius will discuss new cell line development methodologies, including new instrumentation, which are enabling complex […]

The topic of the webinar is Indications, intentions and attitudes towards family formation and it is hosted by ReproUnion’s Fertility Awareness Challenge. MVA is partner in the ReproUnion project, where the regional universities and hospitals are working together to solve five major global reproductive challenges, which are of great individual and social concern.

Date: 9. December 2020 Time: 9:00 (DK time) / 10:00 (IL time) Venue: Online READ MORE & SIGN UP Program Organized by:

Welcome to the 10th meeting of the Medicon Valley Alliance Oncology Network on 8th of December 2020.  Medicon Valley Alliance, together with Lund University and the University of Copenhagen, has the pleasure to invite you to the 10th MVA Oncology Network meeting. This event will focus on transitioning towards personalised medicine for cancer patients by […]